Triumph Science&Technology Co EBITDA per Employee
The EBITDA per Employee of Triumph Science&Technology Co (600552.SS) as of Oct 8, 2026 is 63,822.19 CNY. In the previous year, EBITDA per Employee was 75,464.02 CNY — a change of -15.43% (lower).
Get this data via API
Financial Data API
EBITDA per Employee
63,822.19CNY
YoY
-15.43%
Last updated:
The Triumph Science&Technology Co EBITDA per Employee history
3 Years
10 Years
25 Years
Max
| YEAR | EBITDA per Employee | YoY |
|---|---|---|
| 63,822.19CNY | -15.43% | |
| 75,464.02CNY | +43.82% | |
| 52,472.22CNY | -37.63% | |
| 84,129.61CNY | +13.24% | |
| 74,293.93CNY | +13.62% | |
| 65,387.49CNY | +26.94% | |
| 51,508.74CNY | +45.31% | |
| 35,446.40CNY | +310.23% | |
| 8,640.57CNY | -47.45% | |
| 16,442.23CNY | +6.43% | |
| 15,448.65CNY | -32.40% | |
| 22,853.34CNY | — |
Triumph Science&Technology Co Stock analysis
Frequently Asked Questions about Triumph Science&Technology Co stock
EBITDA per Employee of Triumph Science&Technology Co is 63,822.19 CNY in 2025.
EBITDA per Employee of Triumph Science&Technology Co changed from 75,464.02 CNY to 63,822.19 CNY, representing a -15.43% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBITDA per Employee Triumph Science&Technology Co since 2006 – with annual values, charts, and detailed analysis.
EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.
EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Triumph Science&Technology Co historically and in real time.
Workforce — Triumph Science&Technology Co
All Key Metrics — Triumph Science&Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth